A Curative Immune Profile One Week after Treatment of Indian Kala-Azar Patients Predicts Success with a Short-Course Liposomal Amphotericin B Therapy

BACKGROUND: The present pilot study investigating the minimum dose for short-course single and double-dose treatment of kala-azar with an apparently new liposomal formulation of amphotericin B, Fungisome, led to identification of immunological components for early detection of success and/or failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Mondal, Smriti, Bhattacharya, Pradyot, Rahaman, Mehebubar, Ali, Nahid, Goswami, Rama Prosad
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910702/
https://www.ncbi.nlm.nih.gov/pubmed/20668544
http://dx.doi.org/10.1371/journal.pntd.0000764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910702/
https://www.ncbi.nlm.nih.gov/pubmed/20668544
http://dx.doi.org/10.1371/journal.pntd.0000764

Ejemplares similares